Clinical trial
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
NCT02860897 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- July 31, 2016
- Completion date
- July 31, 2017
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
estrogen, menopause, pelvic floor disorders, surgery